BUBR1 overexpression predicts disease-specific survival after nephroureterectomy in patients with upper tract urothelial carcinoma

To date, there are few reliable markers to distinguish tumors with aggressive characteristics in upper tract urothelial carcinoma. The purpose of this study was to identify a biomarker related to genetic instability (chromosomal instability or microsatellite instability) with prognostic value, in patients with upper tract urothelial carcinoma.

Expression of chromosomal instability-related markers (BUBR1, p53, polo-like kinase 1) and microsatellite instability-related markers (mismatch repair proteins, MLH1 and MSH2) were assessed by immunohistochemistry in 100 patients who had radical nephroureterectomy for upper tract urothelial carcinoma. Numerical aberrations of chromosomes 7, 9 and 17 were evaluated by fluorescence in situ hybridization, which allowed an estimation of the degree of chromosomal instability. BUB1B copy number was examined by array-based comparative genomic hybridization in 32 patients with upper tract urothelial carcinoma.

BUBR1 status was most significantly correlated with chromosomal instability-related and low mismatch repair parameters, according to the molecular biomarkers examined. Overexpression of BUBR1 is frequently detected in tumors with higher histological grade (P < 0.0001) and is significantly associated with chromosomal instability (P = 0.0071). Array-based comparative genomic hybridization revealed that no tumors (0%) showed BUB1B amplification and gain, indicating that overexpression of BUBR1 was independent of BUB1B copy number. For disease-specific survival, BUBR1 overexpression, lymphovascular invasion, pathological tumor stage, pathological lymph node involvement and low MSH2 expression were significant prognostic factors in univariate analyses. In multivariate analyses, BUBR1 overexpression was an independent prognostic factor for disease-specific survival (P = 0.0483, risk ratio 3.76, 95% confidence interval: 1.01-18.43).

BUBR1 may have significant potential as a biomarker for estimating disease-specific survival in patients with upper tract urothelial carcinoma treated by radical nephroureterectomy.

Japanese journal of clinical oncology. 2016 May 12 [Epub ahead of print]

Yoshiaki Yamamoto, Atsunori Oga, Jumpei Akao, Taku Misumi, Nakanori Fuji, Keita Kobayashi, Yoshihisa Kawai, Ryo Inoue, Hiroshi Hirata, Hiroaki Matsumoto, Kazuhiro Nagao, Shigeru Sakano, Hideyasu Matsuyama

Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi., Department of Pathology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi, Japan., Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi., Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi., Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi., Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi., Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi., Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi., Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi., Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi., Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi., Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi., Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Yamaguchi .

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe